- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07593430
The Effect of Aromatherapy Massage-Based Sensory Stımulatıon Program on Cognıtıve and Sensory Functıon ın Intensıve Care Patıents
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: nilgün erdoğan
- Numéro de téléphone: +905312599220
- E-mail: nilgunerdogan37@gmail.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients diagnosed with acute brain injury,
- Glasgow Coma Score (GCS) between 6 and 12,
- Intubated or monitored on oxygen,
- 18 years of age or older,
- Between 24 and 48 hours after hemodynamic vital signs stabilized and without a history of delirium,
- Patients without a history of diseases that increase the risk of odor sensitivity, such as epilepsy or asthma,
Exclusion Criteria:
- Glasgow Coma Score (GCS) below 6,
- Hemodynamic instability,
- Continuously using neuromuscular blocking agents during the study,
- Changes in treatment schedule during the study,
- History of diseases that increase the risk of odor sensitivity, such as epilepsy or asthma,
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: group that applied
aromatherapy
|
Sensory stimulation program performed by a family member of the patient using aromatherapy massage.
|
|
Comparateur placebo: intervention 2
lavender
|
Sensory stimulation program performed by a nurse using aromatherapy massage.
|
|
Comparateur placebo: plasebo group
control
|
routine nursing practice
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Aromatherapy massage, applied twice daily, and sensory stimulation programs administered by family members have an effect on cognitive sensory perception levels (Glasgow Coma Score (GCS)
Délai: 1 year
|
The GCS score ranges from 3 to 15. Eye opening (1-4), motor activity (1-6), and verbal response (1-5) are all indicators. The lowest possible GCS score is 3 for deep coma or death, while the highest is 15 for a fully awake person. In the study, for the control and monitoring of the intervention groups, a 30-minute massage with aromatic oil will be applied to the patient's chest and back half an hour before the start of visiting hours, in accordance with the application protocol. Then, a visit will be made between 11:00 and 11:30, and a sensory stimulation program will be conducted. Patient Identification Form and Patient Monitoring Form will be completed by the interviewer fellows. Similarly, half an hour before visiting hours in the evening, a 30-minute massage with aromatic oil will be applied to the patient's chest and back by the principal investigator. |
1 year
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Aromatherapy massage applied twice daily and sensory stimulation programs administered by family members are effective on cognitive sensory perception levels, Rancho Los Amigos (RLA) Cognitive Function Scale).
Délai: 1 year
|
Aromatherapy massage applied twice daily and sensory stimulation programs administered by family members are effective on cognitive sensory perception levels, Rancho Los Amigos (RLA) Cognitive Function Scale). The Rancho Los Amigos (RLA) Cognitive Function Scale is used to assess behavioral and cognitive patterns of brain damage. The scale indicates the progression of cognitive recovery as demonstrated through behavioral changes. Scores for responses range from 1 to 8; "1" indicates no response (complete help) and "8" purposeful and appropriate response (independent) shown as a cognitive function. In the study, for the control and monitoring of the intervention groups, a 30-minute massage with aromatic oil will be applied to the patient's chest and back half an hour before the start of visiting hours, in accordance with the application protocol. Then, a visit will be made between 11:00 and 11:30, and a sensory stimulation program will be conducted. |
1 year
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The SPSS (Statistical Package for the Social Sciences) 21.0 program will be used to evaluate the obtained data. Data will be expressed as frequency distribution, percentage, mean ± standard deviation.
Délai: 3 mounth
|
The assumption of sphericity will be assessed using Mauchly's sphericity test.
Overall differences between groups will be determined using the Kruskal-Wallis test for quantitative variables and the chi-square test for level of awareness, level of cognitive function, and basic cognitive sensory recovery.
The independent samples t-test, a parametric test used for comparing groups, or the Mann Whitney U test, a non-parametric test, will be used for comparisons between groups.
The significance level will be set at p<0.05.
|
3 mounth
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 10.03.2025/85
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Délai de partage IPD
Type d'informations de prise en charge du partage d'IPD
- SÈVE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .